Cite
MLA Citation
Mette Julsgaard et al.. “Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population‐based cohort study.” Alimentary pharmacology & therapeutics, vol. 54, no. 10, 2021, pp. 1320–1329. http://access.bl.uk/ark:/81055/vdc_100144748678.0x00004e